News

News article 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur congue mollis risus, imperdiet mollis velit convallis eu. Cras dui lorem, scelerisque at felis quis, convallis sodales ante.
News article 1

Four European Countries Contract Possible Corona Vaccine

AstraZeneca heeft afspraken gemaakt met de Inclusieve Vaccin Alliantie (IVA), bestaande uit Nederland, Italië, Frankrijk en Duitsland, over de levering van een toekomstig coronavaccin. AstraZeneca stelt de vaccins beschikbaar zonder winstoogmerk.
Four European Countries Contract Possible Corona Vaccine

Globalstars: Call Singapore

Oproep aan Nederlandse organisaties om een gezamenlijk R&D-projectvoorstel in te dienen met één of meerdere partners in Singapore.
Globalstars: Call Singapore

MIT COVID-19 Challenge; Sequel in The Netherlands

On Friday the 12th of June, a couple of international teams that joined the MIT COVID-19 Challenge at the beginning of April had the opportunity to pitch their solutions against COVID-19 to a group of Dutch stakeholders from the Life Sciences & Health community to explore possibilities to implement their solution in the Netherlands.
MIT COVID-19 Challenge; Sequel in The Netherlands

Sirius Medical Announces CE Mark for Pintuition: to Improve Breast Cancer Surgery

Sirius Medical, a MedTech startup, announced that it has received CE mark approval for Sirius Pintuition. With its debut product, Sirius provides an affordable and easy-to-use alternative to traditional surgical localisation systems that rely on anchor wires or radioactive seeds. Sirius aims to revolutionise the way tumors are localised during surgery.
Sirius Medical Announces CE Mark for Pintuition: to Improve Breast Cancer Surgery

Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidate

Johnson & Johnson announced that through its Janssen Pharmaceutical Companies (Janssen) it has accelerated the initiation of the Phase 1/2a first-in-human clinical trial of its investigational SARS-CoV-2 vaccine, Ad26.COV2-S, recombinant. Initially scheduled to begin in September, the trial is now expected to commence in the second half of July.
Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidate

Annual Report 2019 of Regieorgaan SIA

Het jaar 2019 was een goed jaar voor het praktijkgerichte onderzoek en Regieorgaan SIA. Ze verkenden de toekomst van het praktijkgerichte onderzoek, reikten de eerste Deltapremies uit en ondertekenden met NWO het Kennis en Innovatieconvenant 2020-2023.
Annual Report 2019 of Regieorgaan SIA

News article 2

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur congue mollis risus, imperdiet mollis velit convallis eu. Cras dui lorem, scelerisque at felis quis, convallis sodales ante.
News article 2

Kite Receives European Medicines Agency Approval for CAR T Cell Therapy Manufacturing Facility in Europe

Kite, a Gilead Company (Nasdaq: GILD), announced it has received approval to implement a variation to the Yescarta® (axicabtagene ciloleucel) Marketing Authorization from the European Medicine Agency (EMA) for end-to-end manufacturing. With this approval, Kite’s European manufacturing facility, designed and dedicated to the manufacture of individualised cell therapies, is now fully operational.
Kite Receives European Medicines Agency Approval for CAR T Cell Therapy Manufacturing Facility in Europe

Six More Projects Awarded in COVID-19 Call

Since the foundation of Top Sector LSH, it has supported numerous projects with research into coronaviruses. At the end of March, Health~Holland set up a call for COVID-19 related research proposals. In May we announced that in only one month four projects were awarded by the Health~Holland board. This week we announce the good news that six more projects have been granted PPP Allowance to start their research.
Six More Projects Awarded in COVID-19 Call